|
Evaluation of factors affecting the prognosis of Covid-19 in patients with rheumatic inflammatory diseases: A retrospective multi centric cohort study
|
Kamal Esalatmanesh    , Zahra Soleimani , Mohammadjavad Azadchehr , Alireza Saghazadeh , Roozbeh Esalatmanesh * |
| kashan university of medical siences , esalat.kamal@yahoo.com |
|
|
Abstract: (1770 Views) |
| Introduction: Covid-19 is caused by the SARS-CoV-2 virus, which was first reported in December 2019 in Wuhan, China. Rheumatic diseases include a range of autoimmune disorders, chronic auto inflammatory, and multisystem disease, and those with the disease are at greater risk for developing the infection. This study was performed to evaluate the factors affecting the prognosis of Covid-19 in patients with rheumatic inflammatory diseases. Materials and Methods: This study was performed on 207 rheumatic patients with Covid-19 with PCR positive who referred to three medical centers in Kashan, Tabriz and Tehran from May 2020 to June 2021. Sampling was done by non-probability method and Convenience. The collected data were analyzed by SPSS software version 26 using Chi-square, independent t-test, analysis of variance and logistic regression. Results: The results showed that according to OR values, the chance of poor prognosis among male patients is 4.48 times higher than female patients, in patients with lung disease is 5.55 times higher than patients without lung disease; and among the patients who were in the active phase of rheumatic disease at the time of Covid-19, it is 5.09 times more than the patients who were in the inactive phase of the disease and among the patients whose CT findings were moderate to severe was 25.69 times higher than patients whose CT findings were mild and normal. Conclusion: The results of the present study showed that the prognosis of Covid-19 in rheumatic patients in men, people with underlying lung disease, patients with active phase of rheumatic disease and in those with moderate to severe involvement in CT scan of the lungs is poor. |
|
| Keywords: Rheumatic inflammatory diseases, Prognosis, Covid-19 |
|
|
Full-Text [PDF 1189 kb]
(998 Downloads)
|
Type of Study: Research |
Subject:
medicine, paraclinic
Received: 2021/08/14 | Revised: 2024/09/23 | Accepted: 2021/10/11 | Published: 2021/11/28
|
|
|
|
|
|
|
| Send email to the article author |
|
|
|
| Add your comments about this article |
|
|
|
_-_Copy.png)
.png){kind=logo}
